Osimertinib in Resected EGFR-Mutated NSCLC. Reply. Tsuboi M, Herbst RS, Wu YL. N Engl J Med 2023;389:1342.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tsuboi M, Herbst RS, Wu YL. Osimertinib in Resected EGFR-Mutated NSCLC. Reply. N Engl J Med 2023;389:1342.
PMID: 37792623